Streetbeat News

TCNNF

Trulieve Cannabis Corp

Employees

9,000

Industry

Medicinal and Botanical Manufacturing

Open

7.21

Mkt cap

1.5B

Volume

276K

High

7.85

P/E Ratio

-10.92

52-wk high

14.50

Low

7.21

Div yield

N/A

52-wk low

4.75

Jushi Holdings (OTC:JUSHF) is highlighted by analyst Pablo Zuanic as having significant upside potential in the cannabis market, particularly in Pennsylvania and Virginia due to regulatory shifts. The company's current undervaluation and strategic positioning, including debt management and market expansion, suggest a positive outlook. Zuanic projects a substantial market cap increase for Jushi, outpacing competitors like AYR (OTC:AYRWF), Cresco (OTC:CRLBF), and TerrAscend (OTC:TSNDF), especially if recreational sales commence in these states. Despite challenges, Jushi's operational efficiencies and financial maneuvers indicate resilience and potential for growth.

Portfolio Pulse from Nicolás Jose Rodriguez

February 21, 2024 | 7:35 pm

Zuanic & Associates initiated coverage of Jushi Holdings Inc. with an Overweight rating, citing its undervaluation and strategic positioning in the cannabis sector. The firm highlights Jushi's potential for significant growth, especially with the anticipated shift to recreational cannabis sales in Pennsylvania and Virginia. The analysis also compares Jushi's valuation to other key players in the industry, such as Green Thumb Industries and Curaleaf Holdings, and discusses the broader competitive landscape. Additionally, the report touches on the potential for industry consolidation and Jushi's financial resilience.

Portfolio Pulse from Nicolás Jose Rodriguez

February 21, 2024 | 1:59 pm

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

Pennsylvania Governor Josh Shapiro has proposed the legalization of adult-use cannabis to generate over $250 million in annual revenue and combat the black market. The proposal includes a July 1, 2024, effective date for legalization, with sales starting January 1, 2025, and allocates $5 million towards restorative justice initiatives. Representatives from Cresco Labs and Trulieve participated in a House Health Subcommittee hearing discussing marijuana policy reform.

Portfolio Pulse from Nina Zdinjak

February 07, 2024 | 2:47 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 2, 2024, with notable gainers including Tony G Co-Investment, Global Hemp Group, and Khiron Life Sciences. On the downside, Global Compliance, MJ Holdings, and Rocky Mountain High were among the top losers. Neptune Wellness Solutions, Eastside Distilling, Canopy Growth, cbdMD, Corbus Pharmaceuticals, Tilray Brands, and Cronos Group were notable companies listed on major exchanges that saw price changes.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 9:30 pm

A Florida bill proposing to cap delta-9 THC levels in cannabis products gains momentum, with amendments setting limits at 30% for pre-rolls and whole buds, and 60% for processed substances. The bill, backed by Trulieve Cannabis Corp., progresses as New York faces a lawsuit from women-owned social equity cannabis companies over the licensing process. Meanwhile, Virginia considers treating cannabis like alcohol, proposing a regulated marketplace to start in 2025.

Portfolio Pulse from Jelena Martinovic

February 02, 2024 | 8:44 pm

January saw significant executive and board changes in the cannabis industry. Flora Growth Corp.'s CEO, Clifford Starke, was elected chairman of the U.S. Hemp Roundtable. 4Front Ventures and The Cannabist Company Holdings announced new CEOs. Organigram Holdings and other companies made board appointments, while MedMen Enterprises and BZAM Ltd. saw departures. Trulieve Cannabis appointed a new COO, and other companies expanded their executive teams.

Portfolio Pulse from Jelena Martinovic

February 02, 2024 | 4:01 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.